Dow Up 0.11% Nasdaq Up 0.50%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
3.48 Down 0.01(0.29%) Aug 29, 4:00PM EDT
Prev Close:3.49
Open:3.48
Bid:N/A
Ask:3.53 x 400
1y Target Est:9.67
Beta:2.22
Next Earnings Date:N/A
Day's Range:3.42 - 3.51
52wk Range:2.88 - 5.50
Volume:45,701
Avg Vol (3m):114,688
Market Cap:78.91M
P/E (ttm):N/A
EPS (ttm):-0.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCDown 0.29%78.91M
AZNUp 2.38%96.00B
JNJUp 0.76%292.55B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):58.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.01
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback